FDA Drug Application (203730) for DIVALPROEX SODIUM by AMNEAL PHARMS

Back to FDA Applications sponsored by AMNEAL PHARMS

Application Number203730
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
DosageEQ 250MG VALPROIC ACID
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameDIVALPROEX SODIUM
Active IngredientDIVALPROEX SODIUM

Active IngredientCount
List of drugs with Active Ingredient DIVALPROEX SODIUM4


Back to FDA Applications sponsored by AMNEAL PHARMS